A machine learning-driven framework accurately predicts MPA exposure and supports individualized dosing in childhood-onset LN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results